We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Risk Factors Identified for Pneumonia Following Heart Surgery

By HospiMedica International staff writers
Posted on 14 May 2009
A new study has confirmed that ventilator-associated pneumonia (VAP) is the main cause of nosocomial infections in patients undergoing major heart surgery (MHS), and has also identified the main risk factors.

Researchers from the Hospital General Universitario Gregorio Marañón (HGGM; Madrid, Spain) and 25 other institutions that form part of the European Study Group on Nosocomial Infections (ESGNI; Madrid, Spain) and the European Workgroup of Cardiothoracic Intensivists (EWCI), conducted a prospective study of 971 patients in eight European countries undergoing MHS who developed suspicion of VAP. More...
The researchers found that 4.4% acquired some form of nosocomial infection, and that VAP accounted for almost half of these (2.1%). The microorganisms responsible for VAP were identified as Enterobacteriaceae (45%), Pseudomonas aeruginosa (20%), methicillin-resistant Staphylococcus aureus (MRSA, 10%) and a range of other microorganisms.

The researchers also found that, apart from the amount of time spent on mechanical ventilation, other risk factors for the development of VAP included transfusion requirements, ascending aorta surgery, and the need for reintervention for hemorrhage or cardiac tamponade in the immediate postoperative period. The investigators recommended that anticipative or preemptive antimicrobial therapy should be explored as one of the few potential interventions to avoid VAP in patients remaining under mechanical ventilation for more than 48 hours. The study was published on May 1, 2009, in the open access journal Critical Care, a publication of BioMed Central.

"The crude mortality rate of patients with VAP in our study was found to be 35%; this is significantly more than the mortality rate of 2.3% seen in patients who avoided VAP," said lead author Javier Hortal, M.D., of the department of anesthesia at HGGM. "The overall mortality rate for VAP in patients undergoing MHS may be as high as 16-57%, but many critically ill patients with VAP die because of their underlying disease rather than of pneumonia, which makes analysis difficult."

VAP is a subtype of hospital-acquired pneumonia (HAP), which occurs in people who are on mechanical ventilation that results from an infection which floods the alveoli in the lungs. VAP is distinguished from other kinds of infectious pneumonia because of the different types of microorganisms responsible, antibiotics used to treat, methods of diagnosis, ultimate prognosis, and effective preventive measures.

Related Links:

Hospital General Universitario Gregorio Marañón
European Study Group on Nosocomial Infections




Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.